Clinical Trials Browser

Phase 4 × Unknown × Sarcoma × Clear all

Osteosarcoma

NCT02905916 2016-09-19

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

Phase 4 Unknown

217 enrolled

BreastLymphoidSarcoma

Bone Neoplasms, Breast Neoplasms, Lymphoma

NCT00274885 2011-12-05

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Phase 4 Unknown

58 enrolled

GastrointestinalSarcoma

Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neurotoxicity Syndromes, Gastrointestinal Stromal Tumors

NCT00777504 2011-09-16

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

Phase 4 Unknown

30 enrolled

GastrointestinalGenitourinarySarcoma

Carcinoma, Renal Cell, Gastrointestinal Stromal Tumors

NCT00339118 2006-06-20

EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

Phase 4 Unknown

Sarcoma

Rhabdomyosarcoma

Clinical Trials

Li2CO3

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children